VYN201 for Vitiligo: Promising Data Showcases Potential of BET Inhibition
VYNE Therapeutics' Iain Stuart, PhD, spoke with Dermatology Times to discuss recent phase 1 and pre-clinical data for VYN201 for vitiligo.